Mass spectrometry for the quantification of bioactive peptides in biological fluids.
about
Internal standard strategies for relative and absolute quantitation of peptides in biological matrices by liquid chromatography tandem mass spectrometry.Mechanistic peptidomics: factors that dictate specificity in the formation of endogenous peptides in human milk.Assessment of tandem mass spectrometry and high-resolution mass spectrometry for the analysis of bupivacaine in plasma.Detecting low-abundance vasoactive peptides in plasma: progress toward absolute quantitation using nano liquid chromatography-mass spectrometry.The absolute quantification of endogenous levels of brain neuropeptides in vivo using LC-MS/MS.Bioanalytical approaches to analyzing peptides and proteins by LC--MS/MS.Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry.Recent advances in metabolite identification and quantitative bioanalysis by LC-Q-TOF MS.Quantitation of human peptides and proteins via MS: review of analytically validated assays.Development and Validation of a Reversed-phase HPLC Method for Assay of the Decapeptide Cetrorelix Acetate in Bulk and Pharmaceutical Dosage Forms.Polyelectrolyte-graphene Nanocomposites for Biosensing Applications.LC-MS/MS quantification of parathyroid hormone fragment 1-34 in human plasma.Mass spectrometry measurement of a therapeutic peptide for use in multiple sclerosis.Simultaneous determination of gonadotropin-inhibitory and gonadotropin-releasing hormones using ultra-high performance liquid chromatography electrospray ionization tandem mass spectrometry.Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization.
P2860
Q34310103-DEF9F5FA-A91A-4FAC-878E-FD875A6623D8Q34634913-7820D74F-613E-4247-8C92-DB233DF6709EQ35627328-10639B4F-C8AA-4DD5-8D8F-CB478254F356Q37350114-8955476C-7177-4F7E-A12E-B4BE332701AAQ37885988-90B3168E-4830-4280-94FD-330FFB13AE98Q37890396-433C8E5A-A994-4960-B192-DCC1011D8034Q37893563-83511A80-B096-40EF-998A-27DAF2FB1C77Q38005438-DAFC1C1D-B628-4C09-9607-FC6FFAAF73F6Q38243345-1416522E-279D-44DF-8905-A6235DCF2C7FQ38627852-E083B86C-2009-4CC4-B7DB-484F6F5FA8FFQ38814028-A9DA678B-66DC-426E-9C65-2817E7E2AC1BQ45770022-113E7B93-224B-4077-86DC-5F1198D703ACQ45858747-9136F787-49EE-46C5-A866-D3438BA4AD6BQ48470098-54431A81-974F-4DB6-A482-0112716443F5Q51306832-C10B7D86-B1E3-40A5-8390-37D0F0FB2249
P2860
Mass spectrometry for the quantification of bioactive peptides in biological fluids.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mass spectrometry for the quantification of bioactive peptides in biological fluids.
@ast
Mass spectrometry for the quantification of bioactive peptides in biological fluids.
@en
type
label
Mass spectrometry for the quantification of bioactive peptides in biological fluids.
@ast
Mass spectrometry for the quantification of bioactive peptides in biological fluids.
@en
prefLabel
Mass spectrometry for the quantification of bioactive peptides in biological fluids.
@ast
Mass spectrometry for the quantification of bioactive peptides in biological fluids.
@en
P356
P1476
Mass spectrometry for the quantification of bioactive peptides in biological fluids.
@en
P2093
Constantin Tamvakopoulos
P2860
P304
P356
10.1002/MAS.20120
P577
2007-05-01T00:00:00Z